Individualizing Curative-Intent Therapy in HER2-Positive Early-Stage Breast Cancer

Overview of attention for article published in Current Treatment Options in Oncology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 712)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 25 X posts from 25 X users, with an upper bound of 38,295 followers.

RT @OlgaMartnezSez1: Our new article reviewing the management of HER2+ early breast cancer is now out! Grateful to work with Dr Waks, @DFCI…

RT @OlgaMartnezSez1: Our new article reviewing the management of HER2+ early breast cancer is now out! Grateful to work with Dr Waks, @DFCI…

RT @OlgaMartnezSez1: Our new article reviewing the management of HER2+ early breast cancer is now out! Grateful to work with Dr Waks, @DFCI…

RT @OlgaMartnezSez1: Our new article reviewing the management of HER2+ early breast cancer is now out! Grateful to work with Dr Waks, @DFCI…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.